LDOS stock · NGNE stock

LDOS vs NGNE · P/E 16, rev $8.96B vs $286.5M cap

Leidos Holdings Inc (LDOS) versus Neurogene Inc (NGNE) — a side-by-side from cached financials, not a winner call.

Leidos Holdings Inc (LDOS) is a information technology services company listed on US.

Neurogene Inc (NGNE) is a biotechnology company listed on US.

Latest reported LDOS revenue for 2026-07-03 was $8.96B. Net income was $682.0M. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.

Latest reported NGNE revenue for 2025-09-30 was $0. Net income was -$21.0M. NGNE currently screens at market cap $286.5M.

LDOS currently screens at market cap $20.04B and trailing P/E 15.7. NGNE currently screens at market cap $286.5M.

Not investment advice. Open the LDOS and NGNE stock pages for the full models.

Not investment advice.

Popular Stock Comparisons